Sexual Wellness for Women. These Are Hormonal Symptoms.
Low libido, vaginal dryness, painful intercourse, and reduced arousal are not inevitable parts of aging. They are symptoms of hormonal deficiency and they respond to treatment.
These Are Not Lifestyle Problems. They Are Hormonal.
Most women notice these changes but do not bring them up. Or they are told it is normal and expected with age. It is not.
Female sexual function depends on estrogen and testosterone, both of which decline during perimenopause and menopause. The result is a set of symptoms that are almost universally underreported and undertreated: reduced libido, decreased arousal, vaginal dryness and atrophy, painful intercourse, and difficulty achieving orgasm. These symptoms have measurable hormonal drivers and evidence-based treatments. At Tactus Health, your provider evaluates the full hormone picture before recommending any protocol.
Why Women’s Sexual Health Changes with Hormones
Estrogen maintains vaginal epithelial thickness, lubrication, and pH. When estrogen declines, vaginal tissue thins and becomes less elastic, lubrication decreases, and the tissue becomes more susceptible to irritation and infection. This is genitourinary syndrome of menopause (GSM), and it is not cosmetic. It is structural tissue change driven by estrogen deficiency.
Testosterone drives libido and arousal in women just as in men, and declines just as significantly. Testosterone in women peaks in the mid-20s and falls continuously from there. It drops sharply at menopause and even more dramatically after surgical oophorectomy. When testosterone falls below optimal levels, libido, arousal, and sexual satisfaction decline in ways that estrogen therapy alone cannot fully address. NAMS recognizes testosterone therapy as safe and effective for HSDD in postmenopausal women.
The brain’s role matters too. Dopamine and serotonin pathways regulate desire and reward. Hormonal changes alter these neurotransmitter systems, affecting the psychological dimensions of sexual function alongside the physical ones. Dr. Ashar’s dual board certification in family medicine and psychiatric mental health shapes how the Tactus Health team evaluates both axes of the problem, biological and psychological, before recommending treatment.
Book Confidential ConsultationEstrogen maintains vaginal tissue health. Testosterone drives libido and arousal. Both decline with age and menopause. Both can be addressed through precision HRT. Your provider evaluates the full panel before prescribing.
HRT for sexual wellness is available via telehealth. Labs at any Quest or Labcorp. Prescriptions shipped to your door. Discreet billing.
Estrogen Restores Tissue. Testosterone Restores Desire.
Most women with sexual wellness concerns are dealing with two overlapping mechanisms. Treating only one often leaves the other unresolved.
- Spontaneous sexual desire
- Dopamine-driven arousal
- Motivation and initiation
- Cognitive engagement
- Energy and vitality
- Vaginal tissue health
- Natural lubrication
- Physical comfort
- Genital blood flow
- Sensation and sensitivity
Your provider evaluates both and builds your protocol accordingly.
Your Sexual Symptoms Are Usually Part of a Bigger Hormonal Picture
Most patients who seek care for sexual wellness also experience sleep disruption, mood changes, cognitive fog, and fatigue. These are not separate problems. They are the same underlying hormonal imbalance presenting across multiple systems.
That is why we do not treat symptoms in isolation. A hormone panel that includes estradiol, testosterone, SHBG, FSH, and progesterone tells your provider more than any symptom questionnaire. Labs drive the protocol. We do not guess at dosing.
Book Confidential ConsultationSexual Wellness Symptoms That Respond to Treatment
These are not permanent changes or personality traits. They are symptoms of hormonal deficiency and most respond well to the right treatment.
How We Treat Sexual Dysfunction
The right approach depends on your specific hormone panel, your symptom pattern, and whether you want systemic or local treatment. Your provider evaluates each patient individually before recommending any protocol.
PT-141 (Bremelanotide): Tactus Health also offers PT-141, the only FDA-approved treatment addressing sexual desire through the central nervous system rather than the vascular system. Available for both men and women. See PT-141 details →
Dr. Ashar N.
Dr. Ashar holds a Doctor of Nursing Practice and two national board certifications, one in family practice and one in psychiatric mental health.
She founded Tactus Health to close the gap she watched her own family fall through: symptoms that were real, labs that came back normal, and no one willing to connect the two.
She is responsible for the protocols our medical team follows, and for the training of the clinicians who deliver them. Holding both certifications is why those protocols treat hormones, mood, sleep and metabolism as one system rather than five separate appointments.
Estrogen Feeds the Bacteria That Protect You
Estrogen does not just lubricate. It feeds the healthy bacteria that keep your vaginal environment acidic and protective. Lactobacillus species dominate a healthy vaginal microbiome, producing lactic acid that maintains a pH of 3.8 to 4.5. This acidity prevents the overgrowth of pathogens and acts as a natural barrier against infection.
When estrogen declines, Lactobacillus populations fall and vaginal pH rises. Pathogens that were previously kept in check begin to colonize. The result is the recurrent bacterial vaginosis, yeast infections, and urinary tract infections that are so common in postmenopausal women, and so frequently treated with antibiotics without addressing the underlying hormonal cause.
Restoring estrogen, locally or systemically, restores the Lactobacillus-dominant microbiome, lowers vaginal pH, and dramatically reduces recurrent UTI and infection frequency. Our medical team treats the environment, not just the moisture.
Lactobacillus repopulates. pH returns to acidic range. Recurrent infections resolve. Vaginal estrogen or systemic estradiol both restore the microbiome. Most patients see recurrent UTI frequency drop dramatically within 3 to 4 months of starting estrogen therapy.
Dr. Ashar N.
DNP · APRN · FNP-C · PMHNP-BC · Co-Founder & Medical Director
Dr. Ashar serves as Medical Director and Co-Founder of Tactus Health, setting the clinical protocols our licensed providers follow for every sexual wellness patient. Her dual board certification in family medicine (FNP-C) and psychiatric mental health (PMHNP-BC) equips the Tactus Health team to evaluate sexual health through both lenses simultaneously: hormonal, physical, and where relevant, psychological.
We understand that these are deeply personal conversations. Our telehealth platform is fully encrypted and HIPAA-compliant. Billing is discreet. You can discuss your health goals in a safe, non-judgmental environment. Available in-person in Sugar Hill and via telehealth.
Sexual Wellness FAQ
Not always. Relationship factors, stress, depression, medications (particularly SSRIs and hormonal contraceptives), and trauma all contribute to low libido. But in perimenopausal and postmenopausal women, hormonal decline is almost always a primary factor and is frequently overlooked. A hormone panel is always the right starting point. If labs are normal and libido is still low, other contributors can be explored. More commonly, the labs tell the story.
Yes, at physiological doses. The doses used in women are significantly lower than those used in men. NAMS recognizes testosterone therapy as safe and effective for hypoactive sexual desire disorder (HSDD) in postmenopausal women. Your provider monitors levels closely to keep testosterone in the normal female physiological range and prevent virilizing side effects. Follow-up labs are required.
Yes. Perimenopause begins years, sometimes a decade, before the final menstrual period. Testosterone in women peaks in the mid-20s and declines continuously from there. Hormonal contraceptives suppress testosterone significantly. Postpartum hormonal shifts cause dramatic drops in both estrogen and testosterone. Sexual symptoms from hormonal causes can occur at any reproductive age.
Yes. HRT and hormone prescriptions are available via telehealth. You consult with your provider via video, complete labs at any Quest or Labcorp location, and receive your prescription discreetly by mail.
PT-141 (bremelanotide/Vyleesi) works through the central nervous system by activating melanocortin receptors that regulate sexual desire neurologically. HRT works through tissue restoration and systemic hormone balance. They address different mechanisms and can be used together. PT-141 is FDA-approved for HSDD in premenopausal women and is available as a peptide prescription for both men and women at Tactus Health.
The standard panel includes estradiol, progesterone, total and free testosterone, SHBG (sex hormone binding globulin), FSH, and LH. SHBG is particularly important because high SHBG binds testosterone and makes it biologically unavailable even when total testosterone appears normal. Thyroid panel is added when fatigue, mood, and libido issues coexist. Your provider reviews your specific panel at your consultation.
Find Out What Your Hormones Are Actually Doing.
Your body is not “just changing.” It is responding to measurable hormonal shifts. You do not have to accept it. Your provider will review your labs, symptoms, and goals, and build a plan that fits your biology.
Important Safety Information: Hormone replacement therapy is a prescription medical treatment requiring licensed clinical evaluation. Compounded hormones are not FDA-approved as finished drug products. Women with active estrogen-receptor-positive breast or uterine cancer should discuss risks with their oncologist before considering HRT. Undiagnosed vaginal bleeding requires evaluation prior to initiating hormone therapy. Low-dose testosterone for women is a compounded medication; no FDA-approved formulation exists in the US. Individual results vary. All prescriptions issued by licensed providers following clinical evaluation.